• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21797 Records] Selected Records [0 Hits] [Clear]
Year Source Title
1994     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment with biosynthetic growth hormone in Turner syndrome- primary research
2003     Institute for Clinical Effectiveness and Health Policy (IECS) Treatment with interferon in hepatitis C
1997     The Swedish Council on Health Technology Assessment (SBU) Treatment with neuroleptics: SBU summary and conclusions
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Treatment with pegylated interferon in hepatitis C
2006     HAYES, Inc. Treatment with taxane agents (paclitaxel and docetaxel) for small cell lung cancer
2006     The Swedish Council on Health Technology Assessment (SBU) Treatment with vitamin D and calcium
2021     Agency for Healthcare Research and Quality (AHRQ) Treatments and technologies supporting appropriate opioid tapers
2020     Agency for Healthcare Research and Quality (AHRQ) Treatments for acute pain: a systematic review
2021     Institute for Clinical and Economic Review (ICER) Treatments for anemia in chronic kidney disease: effectiveness and value
2015     Agency for Healthcare Research and Quality (AHRQ) Treatments for ankyloglossia and ankyloglossia with concomitant lip-tie
2017     Agency for Healthcare Research and Quality (AHRQ) Treatments for basal cell and squamous cell carcinoma of the skin
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treatments for benign prostatic hypertrophy
2008     HAYES, Inc. Treatments for binge eating disorder
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for constipation: a review of systematic reviews
2018     NIHR Health Technology Assessment programme Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
2000     NIHR Health Technology Assessment programme Treatments for fatigue in multiple sclerosis: a rapid and systematic review
2016     Agency for Healthcare Research and Quality (AHRQ) Treatments for fecal incontinence
2015     Agency for Healthcare Research and Quality (AHRQ) Treatments for Fibromyalgia in Adult Subgroups
2016     NIHR Health Technology Assessment programme Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment
2011     Agency for Healthcare Research and Quality (AHRQ) Treatments for localized prostate cancer: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation.
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for locally advanced oropharyngeal cancer: a systematic review of clinical effectiveness and cost-effectiveness
2010     VA Technology Assessment Program (VATAP) Treatments for metastatic castrate-resistant prostate cancer
2004     Quality Improvement Scotland (NHS QIS ) Treatments for opiate dependence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for patients with genotype 1 chronic hepatitis C: a review of evidence-based guidelines
2023     Norwegian Institute of Public Health (NIPH) Treatments for relapsing and/or refractory multiple myeloma. A health technology assessment
2013     Agency for Healthcare Research and Quality (AHRQ) Treatments for seasonal allergic rhinitis
2003     NIHR Health Technology Assessment programme Treatments for spasticity and pain in multiple sclerosis: a systematic review
2021     Agency for Healthcare Research and Quality (AHRQ) Treatments, technologies, and models for management of acute and chronic pain in people with a history of substance use disorder
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trebananib in combination with chemotherapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2009     HAYES, Inc. Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Tremelimumab for unresectable pleural or peritoneal malignant mesothelioma – second and third line
2023     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Trends in utilisation of ultrasound by older Australians (2010-2019)
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treprostinil
2015     University of York Triage and minimising crowding in emergency departments
2010     The Swedish Council on Health Technology Assessment (SBU) Triage methods and patient flow processes at emergency departments
2021     Penn Medicine Center for Evidence-based Practice (CEP) Triaging COVID-19 in the emergency department
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2019     NIHR Health Technology Assessment programme Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2013     HAYES, Inc. Triangle tilt surgery for treatment of obstetric brachial plexus injury
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tricyclic antidepressants, clonidine, venlafaxine, and modafinil for the treatment of attention-deficit/hyperactivity disorder in adults: a review of the clinical evidence
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Tridimensional radiotherapy for breast cancer
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Trientine tetrahydrochloride (Cuprior®) [for] the treatment of Wilson's disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Trientine for treatment of Wilson's disease: clinical and cost-effectiveness, and safety
2009     HAYES, Inc. TriFlange acetabular prosthesis for failed total hip arthroplasty with massive acetabular defects
2016     HAYES, Inc. Trifluridine-tipiracil (Lonsurf) for refractory metastatic colorectal cancer
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Trigeminal nerve stimulation to treat neuralgia
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for chronic non-malignant musculoskeletal pain
2009     HAYES, Inc. Trigger point injections for myofascial pain
2013     HAYES, Inc. Trigger point injections for myofascial pain
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for non-malignant chronic pain
2010     Adelaide Health Technology Assessment (AHTA) Triggerfish continuous intraocular pressure monitoring system for the improved management of glaucoma patients
2022     Swiss Federal Office of Public Health (FOPH) Trimonthly vs. monthly use of bone-targeted agents in patients with bone metastases and multiple myeloma
2021     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Triphasic biomaterial for augmentation of the osteoporotic femoral neck
2021     Austrian Institute for Health Technology Assessment (AIHTA) Triphasic biomaterial for augmentation of the osteoporotic femoral neck: systematic review
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Triple therapy for COPD
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2018     NIHR Health Technology Assessment programme Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2019     Penn Medicine Center for Evidence-based Practice (CEP) Triple-lumen peripherally-inserted central catheters
2000     British Columbia Office of Health Technology Assessment (BCOHTA) Triple-marker screening in British Columbia: current practice, future options
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2016     NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2011     HAYES, Inc. Trofile™ HIV tropism assay
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Troglitazone for Type II diabetes
2008     NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) TruScan
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2006     National Institute for Health and Care Excellence (NICE) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control
2010     HAYES, Inc. Tuberous Sclerosis Complex (TSC; Bourneville Disease)
2002     Health Technology Advisory Committee (HTAC) Tumescent liposuction
2001     HAYES, Inc. Tumescent liposuction
2011     HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2024     Swiss Federal Office of Public Health (FOPH) Tumor treating fields (TTFields) therapy for patients with glioblastoma multiforme
2003     The Swedish Council on Health Technology Assessment (SBU) Tumor vaccination- early assessment briefs (Alert)
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Economic efficiency
2002     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Medical efficacy
2016     NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2023     Scottish Health Technologies Group (SHTG) Tumour profiling tests to guide chemotherapy decisions in early breast cancer
2003     The Swedish Council on Health Technology Assessment (SBU) TUNA - Transurethral needle ablation for BPH - early assessment briefs (Alert)
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2014     Health Quality Ontario (HQO) Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2014     Health Quality Ontario (HQO) Turning for ulcer reduction (TURN) study: an economic analysis
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2018     NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2020     NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2022     Medical Services Advisory Committee (MSAC) Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer disease
2006     University HealthSystem Consortium (UHC) Tygacil
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2017     Agency for Healthcare Research and Quality (AHRQ) Tympanostomy tubes in children with otitis media
2004     National Institute for Clinical Excellence (NICE) Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults
2004     National Institute for Clinical Excellence (NICE) Type 2 diabetes: Prevention and management of foot problems
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment
2012     NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2014     Malaysian Health Technology Assessment (MaHTAS) Typhoid carrier test (Typhidot-C)
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating ALK mutation-positive advanced non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating MET mutation-positive metastatic non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors, immune checkpoint inhibitors and everolimus for treating advanced renal cell cancer
2010     HAYES, Inc. UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer